-
1
-
-
0032506055
-
Phenotypic mechanism of HIV-1 resistance to 3′-azido-3′- deoxythymidine (AZT): Increased polymerization processivity and enhanced sensitivity to pyrophosphate of the mutant viral reverse transcriptase
-
Arion, D., N. Kaushik, S. McCormick, G. Borkow, and M. A. Parniak. 1998. Phenotypic mechanism of HIV-1 resistance to 3′-azido-3′- deoxythymidine (AZT): increased polymerization processivity and enhanced sensitivity to pyrophosphate of the mutant viral reverse transcriptase. Biochemistry 37: 15908-15917.
-
(1998)
Biochemistry
, vol.37
, pp. 15908-15917
-
-
Arion, D.1
Kaushik, N.2
McCormick, S.3
Borkow, G.4
Parniak, M.A.5
-
2
-
-
0041366954
-
Nevirapine-selected mutations Y181I/C of HIV-1 reverse transcriptase confer cross-resistance to stavudine
-
Baldanti, F., S. Paolucci, G. Maga, N. Labo, U. Hubscher, A. Y. Skoblov, L. Victorova, S. Spadari, L. Minoli, and G. Gerna. 2003. Nevirapine-selected mutations Y181I/C of HIV-1 reverse transcriptase confer cross-resistance to stavudine. AIDS 17:1568-1570.
-
(2003)
AIDS
, vol.17
, pp. 1568-1570
-
-
Baldanti, F.1
Paolucci, S.2
Maga, G.3
Labo, N.4
Hubscher, U.5
Skoblov, A.Y.6
Victorova, L.7
Spadari, S.8
Minoli, L.9
Gerna, G.10
-
3
-
-
0038182520
-
Nevirapine resistance mutation at codon 181 of the HIV-1 reverse transcriptase confers stavudine resistance by increasing nucleotide substrate discrimination and phosphorolytic activity
-
Blanca, G., F. Baldanti, S. Paolucci, A. Y. Skoblov, L. Victorova, U. Hubscher, G. Gerna, S. Spadari, and G. Maga. 2003. Nevirapine resistance mutation at codon 181 of the HIV-1 reverse transcriptase confers stavudine resistance by increasing nucleotide substrate discrimination and phosphorolytic activity. J. Biol. Chem. 278:15469-15472.
-
(2003)
J. Biol. Chem.
, vol.278
, pp. 15469-15472
-
-
Blanca, G.1
Baldanti, F.2
Paolucci, S.3
Skoblov, A.Y.4
Victorova, L.5
Hubscher, U.6
Gerna, G.7
Spadari, S.8
Maga, G.9
-
4
-
-
0035031936
-
Selective excision of AZTMP by drug-resistant human immunodeficiency virus reverse transcriptase
-
Boyer, P. L., S. G. Sarafianos, E. Arnold, and S. H. Hughes. 2001. Selective excision of AZTMP by drug-resistant human immunodeficiency virus reverse transcriptase. J. Virol. 75:4832-4842.
-
(2001)
J. Virol.
, vol.75
, pp. 4832-4842
-
-
Boyer, P.L.1
Sarafianos, S.G.2
Arnold, E.3
Hughes, S.H.4
-
5
-
-
34547105526
-
Selection of mutations in the connection and RNase H domains of human immunodeficiency virus type 1 reverse transcriptase that increase resistance to 3′-azido-3′-dideoxythymidine
-
Brehm, J. H., D. Koontz, J. D. Meteer, V. Pathak, N. Sluis-Cremer, and J. W. Mellors. 2007. Selection of mutations in the connection and RNase H domains of human immunodeficiency virus type 1 reverse transcriptase that increase resistance to 3′-azido-3′-dideoxythymidine. J. Virol. 81:7852-7859.
-
(2007)
J. Virol.
, vol.81
, pp. 7852-7859
-
-
Brehm, J.H.1
Koontz, D.2
Meteer, J.D.3
Pathak, V.4
Sluis-Cremer, N.5
Mellors, J.W.6
-
6
-
-
1842509978
-
Positive selection detection in 40,000 human immunodeficiency virus (HIV) type 1 sequences automatically identifies drug resistance and positive fitness mutations in HIV protease and reverse transcriptase
-
Chen, L., A. Perlina, and C. J. Lee. 2004. Positive selection detection in 40,000 human immunodeficiency virus (HIV) type 1 sequences automatically identifies drug resistance and positive fitness mutations in HIV protease and reverse transcriptase. J. Virol. 78:3722-3732.
-
(2004)
J. Virol.
, vol.78
, pp. 3722-3732
-
-
Chen, L.1
Perlina, A.2
Lee, C.J.3
-
7
-
-
34250811908
-
Mutations in human immunodeficiency virus type 1 RNase H primer grip enhance 3′-azido-3′-deoxythymidine resistance
-
Delviks-Frankenberry, K. A., G. N. Nikolenko, R. Barr, and V. K. Pathak. 2007. Mutations in human immunodeficiency virus type 1 RNase H primer grip enhance 3′-azido-3′-deoxythymidine resistance. J. Virol. 81:6837-6845.
-
(2007)
J. Virol.
, vol.81
, pp. 6837-6845
-
-
Delviks-Frankenberry, K.A.1
Nikolenko, G.N.2
Barr, R.3
Pathak, V.K.4
-
8
-
-
52049107430
-
Connection domain mutations N348I and A360V in HIV-1 reverse transcriptase enhance resistance to AZT to 3′-azido-3′- deoxythymidine through both RNase H-dependent and -independent mechanisms
-
Ehteshami, M., G. L. Beilhartz, B. J. Scarth, E. P. Tchesnokov, S. McCormick, B. Wynhoven, P. R. Harrigan, and M. Gotte. 2008. Connection domain mutations N348I and A360V in HIV-1 reverse transcriptase enhance resistance to AZT to 3′-azido-3′-deoxythymidine through both RNase H-dependent and -independent mechanisms. J. Biol. Chem. 283:22222-22232.
-
(2008)
J. Biol. Chem.
, vol.283
, pp. 22222-22232
-
-
Ehteshami, M.1
Beilhartz, G.L.2
Scarth, B.J.3
Tchesnokov, E.P.4
McCormick, S.5
Wynhoven, B.6
Harrigan, P.R.7
Gotte, M.8
-
9
-
-
77951234887
-
Beyond codon 240: Mutations in the HIV-1 reverse transcriptase selected after exposure to antiretrovirals
-
Galli, R., B. Wynhoven, B. Sattha, G. Tachedjian, and P. Harrigan. 2004. Beyond codon 240: mutations in the HIV-1 reverse transcriptase selected after exposure to antiretrovirals. eJIAS 1.
-
(2004)
EJIAS
, vol.1
-
-
Galli, R.1
Wynhoven, B.2
Sattha, B.3
Tachedjian, G.4
Harrigan, P.5
-
10
-
-
0024999452
-
Retroviral reverse transcriptase: Synthesis, structure, and function
-
Goff, S. P. 1990. Retroviral reverse transcriptase: synthesis, structure, and function. J. Acquir. Immune Defic. Syndr. 3:817-831.
-
(1990)
J. Acquir. Immune Defic. Syndr.
, vol.3
, pp. 817-831
-
-
Goff, S.P.1
-
11
-
-
41149145592
-
Amino acid mutation N348I in the connection subdomain of human immunodeficiency virus type 1 reverse transcriptase confers multiclass resistance to nucleoside and nonnucleoside reverse transcriptase inhibitors
-
Hachiya, A., E. N. Kodama, S. G. Sarafianos, M. M. Schuckmann, Y. Sakagami, M. Matsuoka, M. Takiguchi, H. Gatanaga, and S. Oka. 2008. Amino acid mutation N348I in the connection subdomain of human immunodeficiency virus type 1 reverse transcriptase confers multiclass resistance to nucleoside and nonnucleoside reverse transcriptase inhibitors. J. Virol. 82: 3261-3270.
-
(2008)
J. Virol.
, vol.82
, pp. 3261-3270
-
-
Hachiya, A.1
Kodama, E.N.2
Sarafianos, S.G.3
Schuckmann, M.M.4
Sakagami, Y.5
Matsuoka, M.6
Takiguchi, M.7
Gatanaga, H.8
Oka, S.9
-
12
-
-
64749091545
-
Clinical relevance of substitutions in the connection subdomain and RNase H domain of HIV-1 reverse transcriptase from a cohort of antiretroviral treatment-naive patients
-
Hachiya, A., K. Shimane, S. G. Sarafianos, E. N. Kodama, Y. Sakagami, F. Negishi, H. Koizumi, H. Gatanaga, M. Matsuoka, M. Takiguchi, and S. Oka. 2009. Clinical relevance of substitutions in the connection subdomain and RNase H domain of HIV-1 reverse transcriptase from a cohort of antiretroviral treatment-naive patients. Antiviral Res. 82:115-121.
-
(2009)
Antiviral Res.
, vol.82
, pp. 115-121
-
-
Hachiya, A.1
Shimane, K.2
Sarafianos, S.G.3
Kodama, E.N.4
Sakagami, Y.5
Negishi, F.6
Koizumi, H.7
Gatanaga, H.8
Matsuoka, M.9
Takiguchi, M.10
Oka, S.11
-
13
-
-
0027318776
-
Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA
-
Jacobo-Molina, A., J. Ding, R. G. Nanni, A. D. Clark, Jr., X. Lu, C. Tantillo, R. L. Williams, G. Kamer, A. L. Ferris, P. Clark, et al. 1993. Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA. Proc. Natl. Acad. Sci. U. S. A. 90:6320-6324.
-
(1993)
Proc. Natl. Acad. Sci. U. S. A.
, vol.90
, pp. 6320-6324
-
-
Jacobo-Molina, A.1
Ding, J.2
Nanni, R.G.3
Clark Jr., A.D.4
Lu, X.5
Tantillo, C.6
Williams, R.L.7
Kamer, G.8
Ferris, A.L.9
Clark, P.10
-
14
-
-
0026693137
-
Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor
-
Kohlstaedt, L. A., J. Wang, J. M. Friedman, P. A. Rice, and T. A. Steitz. 1992. Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science 256:1783-1790.
-
(1992)
Science
, vol.256
, pp. 1783-1790
-
-
Kohlstaedt, L.A.1
Wang, J.2
Friedman, J.M.3
Rice, P.A.4
Steitz, T.A.5
-
15
-
-
0343811737
-
Single-step kinetics of HIV-1 reverse transcriptase mutants responsible for virus resistance to nucleoside inhibitors zidovudine and 3-TC
-
Krebs, R., U. Immendorfer, S. H. Thrall, B. M. Wohrl, and R. S. Goody. 1997. Single-step kinetics of HIV-1 reverse transcriptase mutants responsible for virus resistance to nucleoside inhibitors zidovudine and 3-TC. Biochemistry 36:10292-10300.
-
(1997)
Biochemistry
, vol.36
, pp. 10292-10300
-
-
Krebs, R.1
Immendorfer, U.2
Thrall, S.H.3
Wohrl, B.M.4
Goody, R.S.5
-
16
-
-
0345306634
-
Thymidine analogue reverse transcriptase inhibitors resistance mutations profiles and association to other nucleoside reverse transcriptase inhibitors resistance mutations observed in the context of virological failure
-
Marcelin, A. G., C. Delaugerre, M. Wirden, P. Viegas, A. Simon, C. Katlama, and V. Calvez. 2004. Thymidine analogue reverse transcriptase inhibitors resistance mutations profiles and association to other nucleoside reverse transcriptase inhibitors resistance mutations observed in the context of virological failure. J. Med. Virol. 72:162-165.
-
(2004)
J. Med. Virol.
, vol.72
, pp. 162-165
-
-
Marcelin, A.G.1
Delaugerre, C.2
Wirden, M.3
Viegas, P.4
Simon, A.5
Katlama, C.6
Calvez, V.7
-
17
-
-
0033165851
-
A mechanism of AZT resistance: An increase in nucleotide-dependent primer unblocking by mutant HIV-1 reverse transcriptase
-
Meyer, P. R., S. E. Matsuura, A. M. Mian, A. G. So, and W. A. Scott. 1999. A mechanism of AZT resistance: an increase in nucleotide-dependent primer unblocking by mutant HIV-1 reverse transcriptase. Mol. Cell 4:35-43.
-
(1999)
Mol. Cell
, vol.4
, pp. 35-43
-
-
Meyer, P.R.1
Matsuura, S.E.2
Mian, A.M.3
So, A.G.4
Scott, W.A.5
-
18
-
-
33846063300
-
Mutations in the connection domain of HIV-1 reverse transcriptase increase 3′-azido-3′-deoxythymidine resistance
-
Nikolenko, G. N., K. A. Delviks-Frankenberry, S. Palmer, F. Maldarelli, M. J. Fivash, Jr., J. M. Coffin, and V. K. Pathak. 2007. Mutations in the connection domain of HIV-1 reverse transcriptase increase 3′-azido- 3′-deoxythymidine resistance. Proc. Natl. Acad. Sci. U. S. A. 104:317-322.
-
(2007)
Proc. Natl. Acad. Sci. U. S. A.
, vol.104
, pp. 317-322
-
-
Nikolenko, G.N.1
Delviks-Frankenberry, K.A.2
Palmer, S.3
Maldarelli, F.4
Fivash Jr., M.J.5
Coffin, J.M.6
Pathak, V.K.7
-
19
-
-
13844312476
-
Mechanism for nucleoside analog-mediated abrogation of HIV-1 replication: Balance between RNase H activity and nucleotide excision
-
Nikolenko, G. N., S. Palmer, F. Maldarelli, J. W. Mellors, J. M. Coffin, and V. K. Pathak. 2005. Mechanism for nucleoside analog-mediated abrogation of HIV-1 replication: balance between RNase H activity and nucleotide excision. Proc. Natl. Acad. Sci. U. S. A. 102:2093-2098.
-
(2005)
Proc. Natl. Acad. Sci. U. S. A.
, vol.102
, pp. 2093-2098
-
-
Nikolenko, G.N.1
Palmer, S.2
Maldarelli, F.3
Mellors, J.W.4
Coffin, J.M.5
Pathak, V.K.6
-
20
-
-
35848960087
-
Variations in reverse transcriptase and RNase H domain mutations in human immunodeficiency virus type 1 clinical isolates are associated with divergent phenotypic resistance to zidovudine
-
Ntemgwa, M., M. A. Wainberg, M. Oliveira, D. Moisi, R. Lalonde, V. Micheli, and B. G. Brenner. 2007. Variations in reverse transcriptase and RNase H domain mutations in human immunodeficiency virus type 1 clinical isolates are associated with divergent phenotypic resistance to zidovudine. Antimicrob. Agents Chemother. 51:3861-3869.
-
(2007)
Antimicrob. Agents Chemother.
, vol.51
, pp. 3861-3869
-
-
Ntemgwa, M.1
Wainberg, M.A.2
Oliveira, M.3
Moisi, D.4
Lalonde, R.5
Micheli, V.6
Brenner, B.G.7
-
21
-
-
0037625913
-
Detection of a new HIV-1 reverse transcriptase mutation (Q145M) conferring resistance to nucleoside and non-nucleoside inhibitors in a patient failing highly active antiretroviral therapy
-
Paolucci, S., F. Baldanti, M. Tinelli, G. Maga, and G. Gerna. 2003. Detection of a new HIV-1 reverse transcriptase mutation (Q145M) conferring resistance to nucleoside and non-nucleoside inhibitors in a patient failing highly active antiretroviral therapy. AIDS 17:924-927.
-
(2003)
AIDS
, vol.17
, pp. 924-927
-
-
Paolucci, S.1
Baldanti, F.2
Tinelli, M.3
Maga, G.4
Gerna, G.5
-
22
-
-
0942290559
-
Natural variation of drug susceptibility in wild-type human immunodeficiency virus type 1
-
Parkin, N. T., N. S. Hellmann, J. M. Whitcomb, L. Kiss, C. Chappey, and C. J. Petropoulos. 2004. Natural variation of drug susceptibility in wild-type human immunodeficiency virus type 1. Antimicrob. Agents Chemother. 48: 437-443.
-
(2004)
Antimicrob. Agents Chemother.
, vol.48
, pp. 437-443
-
-
Parkin, N.T.1
Hellmann, N.S.2
Whitcomb, J.M.3
Kiss, L.4
Chappey, C.5
Petropoulos, C.J.6
-
23
-
-
0034019566
-
A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1
-
Petropoulos, C. J., N. T. Parkin, K. L. Limoli, Y. S. Lie, T. Wrin, W. Huang, H. Tian, D. Smith, G. A. Winslow, D. J. Capon, and J. M. Whitcomb. 2000. A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1. Antimicrob. Agents Chemother. 44:920-928.
-
(2000)
Antimicrob. Agents Chemother.
, vol.44
, pp. 920-928
-
-
Petropoulos, C.J.1
Parkin, N.T.2
Limoli, K.L.3
Lie, Y.S.4
Wrin, T.5
Huang, W.6
Tian, H.7
Smith, D.8
Winslow, G.A.9
Capon, D.J.10
Whitcomb, J.M.11
-
24
-
-
0037250521
-
Human immunodeficiency virus reverse transcriptase and protease sequence database
-
Rhee, S. Y., M. J. Gonzales, R. Kantor, B. J. Betts, J. Ravela, and R. W. Shafer. 2003. Human immunodeficiency virus reverse transcriptase and protease sequence database. Nucleic Acids Res. 31:298-303.
-
(2003)
Nucleic Acids Res.
, vol.31
, pp. 298-303
-
-
Rhee, S.Y.1
Gonzales, M.J.2
Kantor, R.3
Betts, B.J.4
Ravela, J.5
Shafer, R.W.6
-
25
-
-
0026318387
-
Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture
-
Richman, D., C. K. Shih, I. Lowy, J. Rose, P. Prodanovich, S. Goff, and J. Griffin. 1991. Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture. Proc. Natl. Acad. Sci. U. S. A. 88:11241-11245.
-
(1991)
Proc. Natl. Acad. Sci. U. S. A.
, vol.88
, pp. 11241-11245
-
-
Richman, D.1
Shih, C.K.2
Lowy, I.3
Rose, J.4
Prodanovich, P.5
Goff, S.6
Griffin, J.7
-
26
-
-
0027957791
-
Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy
-
Richman, D. D., D. Havlir, J. Corbeil, D. Looney, C. Ignacio, S. A. Spector, J. Sullivan, S. Cheeseman, K. Barringer, D. Pauletti, et al. 1994. Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy. J. Virol. 68:1660-1666.
-
(1994)
J. Virol.
, vol.68
, pp. 1660-1666
-
-
Richman, D.D.1
Havlir, D.2
Corbeil, J.3
Looney, D.4
Ignacio, C.5
Spector, S.A.6
Sullivan, J.7
Cheeseman, S.8
Barringer, K.9
Pauletti, D.10
-
27
-
-
33846804137
-
Relationship between mutations in HIV-1 RNase H domain and nucleoside reverse transcriptase inhibitors resistance mutations in naive and pre-treated HIV infected patients
-
Roquebert, B., M. Wirden, A. Simon, J. Deval, C. Katlama, V. Calvez, and A. G. Marcelin. 2007. Relationship between mutations in HIV-1 RNase H domain and nucleoside reverse transcriptase inhibitors resistance mutations in naive and pre-treated HIV infected patients. J. Med. Virol. 79:207-211.
-
(2007)
J. Med. Virol.
, vol.79
, pp. 207-211
-
-
Roquebert, B.1
Wirden, M.2
Simon, A.3
Deval, J.4
Katlama, C.5
Calvez, V.6
Marcelin, A.G.7
-
28
-
-
0033621167
-
Lamivudine (3TC) resistance in HIV-1 reverse transcriptase involves steric hindrance with beta-branched amino acids
-
Sarafianos, S. G., K. Das, A. D. Clark, Jr., J. Ding, P. L. Boyer, S. H. Hughes, and E. Arnold. 1999. Lamivudine (3TC) resistance in HIV-1 reverse transcriptase involves steric hindrance with beta-branched amino acids. Proc. Natl. Acad. Sci. U. S. A. 96:10027-10032.
-
(1999)
Proc. Natl. Acad. Sci. U. S. A.
, vol.96
, pp. 10027-10032
-
-
Sarafianos, S.G.1
Das, K.2
Clark Jr., A.D.3
Ding, J.4
Boyer, P.L.5
Hughes, S.H.6
Arnold, E.7
-
29
-
-
0025325983
-
The "megaprimer" method of sitedirected mutagenesis
-
Sarkar, G., and S. S. Sommer. 1990. The "megaprimer" method of sitedirected mutagenesis. Biotechniques 8:404-407.
-
(1990)
Biotechniques
, vol.8
, pp. 404-407
-
-
Sarkar, G.1
Sommer, S.S.2
-
30
-
-
0033770149
-
Molecular mechanisms of HIV-1 resistance to nucleoside reverse transcriptase inhibitors (NRTIs)
-
Sluis-Cremer, N., D. Arion, and M. A. Parniak. 2000. Molecular mechanisms of HIV-1 resistance to nucleoside reverse transcriptase inhibitors (NRTIs). Cell. Mol. Life Sci. 57:1408-1422.
-
(2000)
Cell. Mol. Life Sci.
, vol.57
, pp. 1408-1422
-
-
Sluis-Cremer, N.1
Arion, D.2
Parniak, M.A.3
-
31
-
-
0028271687
-
Structure of the binding site for nonnucleoside inhibitors of the reverse transcriptase of human immunodeficiency virus type 1
-
Smerdon, S. J., J. Jager, J. Wang, L. A. Kohlstaedt, A. J. Chirino, J. M. Friedman, P. A. Rice, and T. A. Steitz. 1994. Structure of the binding site for nonnucleoside inhibitors of the reverse transcriptase of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. U. S. A. 91:3911-3915.
-
(1994)
Proc. Natl. Acad. Sci. U. S. A.
, vol.91
, pp. 3911-3915
-
-
Smerdon, S.J.1
Jager, J.2
Wang, J.3
Kohlstaedt, L.A.4
Chirino, A.J.5
Friedman, J.M.6
Rice, P.A.7
Steitz, T.A.8
-
32
-
-
0035912717
-
Nonnucleoside reverse transcriptase inhibitors are chemical enhancers of dimerization of the HIV type 1 reverse transcriptase
-
Tachedjian, G., M. Orlova, S. G. Sarafianos, E. Arnold, and S. P. Goff. 2001. Nonnucleoside reverse transcriptase inhibitors are chemical enhancers of dimerization of the HIV type 1 reverse transcriptase. Proc. Natl. Acad. Sci. U. S. A. 98:7188-7193.
-
(2001)
Proc. Natl. Acad. Sci. U. S. A.
, vol.98
, pp. 7188-7193
-
-
Tachedjian, G.1
Orlova, M.2
Sarafianos, S.G.3
Arnold, E.4
Goff, S.P.5
-
33
-
-
0028172345
-
Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase. Implications for mechanisms of drug inhibition and resistance
-
Tantillo, C., J. Ding, A. Jacobo-Molina, R. G. Nanni, P. L. Boyer, S. H. Hughes, R. Pauwels, K. Andries, P. A. Janssen, and E. Arnold. 1994. Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase. Implications for mechanisms of drug inhibition and resistance. J. Mol. Biol. 243:369-387.
-
(1994)
J. Mol. Biol.
, vol.243
, pp. 369-387
-
-
Tantillo, C.1
Ding, J.2
Jacobo-Molina, A.3
Nanni, R.G.4
Boyer, P.L.5
Hughes, S.H.6
Pauwels, R.7
Andries, K.8
Janssen, P.A.9
Arnold, E.10
-
34
-
-
0028360742
-
Structural basis of asymmetry in the human immunodeficiency virus type 1 reverse transcriptase heterodimer
-
Wang, J., S. J. Smerdon, J. Jager, L. A. Kohlstaedt, P. A. Rice, J. M. Friedman, and T. A. Steitz. 1994. Structural basis of asymmetry in the human immunodeficiency virus type 1 reverse transcriptase heterodimer. Proc. Natl. Acad. Sci. U. S. A. 91:7242-7246.
-
(1994)
Proc. Natl. Acad. Sci. U. S. A.
, vol.91
, pp. 7242-7246
-
-
Wang, J.1
Smerdon, S.J.2
Jager, J.3
Kohlstaedt, L.A.4
Rice, P.A.5
Friedman, J.M.6
Steitz, T.A.7
-
35
-
-
0026100860
-
A novel dipyridodiazepinone inhibitor of HIV-1 reverse transcriptase acts through a nonsubstrate binding site
-
Wu, J. C., T. C. Warren, J. Adams, J. Proudfoot, J. Skiles, P. Raghavan, C. Perry, I. Potocki, P. R. Farina, and P. M. Grob. 1991. A novel dipyridodiazepinone inhibitor of HIV-1 reverse transcriptase acts through a nonsubstrate binding site. Biochemistry 30:2022-2026.
-
(1991)
Biochemistry
, vol.30
, pp. 2022-2026
-
-
Wu, J.C.1
Warren, T.C.2
Adams, J.3
Proudfoot, J.4
Skiles, J.5
Raghavan, P.6
Perry, C.7
Potocki, I.8
Farina, P.R.9
Grob, P.M.10
-
36
-
-
38049028352
-
N348I in the connection domain of HIV-1 reverse transcriptase confers zidovudine and nevirapine resistance
-
Yap, S. H., C. W. Sheen, J. Fahey, M. Zanin, D. Tyssen, V. D. Lima, B. Wynhoven, M. Kuiper, N. Sluis-Cremer, P. R. Harrigan, and G. Tachedjian. 2007. N348I in the connection domain of HIV-1 reverse transcriptase confers zidovudine and nevirapine resistance. PLoS Med. 4:e335.
-
(2007)
PLoS Med.
, vol.4
-
-
Yap, S.H.1
Sheen, C.W.2
Fahey, J.3
Zanin, M.4
Tyssen, D.5
Lima, V.D.6
Wynhoven, B.7
Kuiper, M.8
Sluis-Cremer, N.9
Harrigan, P.R.10
Tachedjian, G.11
|